BICO Group AB (publ) (FRA:49Z)

Market Cap	115.56M -34.1%
Revenue (ttm)	161.01M +10.6%
Net Income	-61.87M
EPS	-0.88
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	357
Open	1.718
Previous Close	1.680
Day's Range	1.718 - 1.718
52-Week Range	1.573 - 4.100
Beta	n/a
RSI	41.51
Earnings Date	Feb 18, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2016
• Employees: 586
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 49Z

Financial Performance

In 2024, BICO Group AB's revenue was 1.95 billion, a decrease of -3.19% compared to the previous year's 2.01 billion. Losses were -5.50 million, -99.53% less than in 2023.

Financial numbers in SEK